Feasibility of MR-guided stereotactic ablative body radiotherapy of lymph node oligometastases

被引：0
|
作者：
Batumalai, V. [1 ]
Crawford, D. [1 ]
Pagulayan, C. [1 ]
Hogan, L. [1 ]
Jelen, U. [1 ]
Loo, C. [1 ]
Dunkerley, N. [1 ]
Picton, M. [1 ]
Geddes, L. [1 ]
Alvares, S. [1 ]
Sampaio, S. [1 ]
Heinke, M. [1 ]
Twentyman, T. [1 ]
Jameson, M. [1 ]
de Leon, J. [1 ]
机构：
[1] GenesisCare, Radiat Oncol, Sydney, NSW, Australia
来源：
RADIOTHERAPY AND ONCOLOGY | 2022年 / 170卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO-0649
引用
收藏
页码：S584 / S584
页数：1
相关论文
共 50 条
  • [31] Pulmonary oligometastases: Metastasectomy or stereotactic ablative radiotherapy?
    Widder, Joachim
    Klinkenberg, Theo J.
    Ubbels, Jan F.
    Wiegman, Erwin M.
    Groen, Harry J. M.
    Langendijk, Johannes A.
    RADIOTHERAPY AND ONCOLOGY, 2013, 107 (03) : 409 - 413
  • [32] Adapting outside the box: Simulation-free MR-guided stereotactic ablative radiotherapy for prostate cancer
    de Leon, Jeremiah
    Jelen, Urszula
    Carr, Madeline
    Crawford, David
    Picton, Maddison
    Tran, Charles
    McKenzie, Laura
    Peng, Valery
    Twentyman, Tania
    Jameson, Michael G.
    Batumalai, Vikneswary
    RADIOTHERAPY AND ONCOLOGY, 2024, 200
  • [33] Feasibility of magnetic resonance-guided stereotactic ablative body radiotherapy of liver cancer
    Picton, M.
    Batumalai, V.
    Crawford, D.
    Pagulayan, C.
    Hogan, L.
    Jelen, U.
    Loo, C.
    Dunkerley, N.
    Geddes, L.
    Sampaio, S.
    Heinke, M.
    Twentyman, T.
    Jameson, M.
    de Leon, J.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S298 - S299
  • [34] Stereotactic body radiotherapy for oligometastases
    Tree, Alison C.
    Khoo, Vincent S.
    Eeles, Rosalind A.
    Ahmed, Merina
    Dearnaley, David P.
    Hawkins, Maria A.
    Huddart, Robert A.
    Nutting, Christopher M.
    Ostler, Peter J.
    van As, Nicholas J.
    LANCET ONCOLOGY, 2013, 14 (01): : E28 - E37
  • [35] Safety of Pembrolizumab Combined with Stereotactic Ablative Body Radiotherapy (SABR) for Pulmonary Oligometastases
    Siva, S.
    Bressel, M.
    Loi, S.
    Sandhu, S.
    Tran, B.
    Mooi, J.
    Lewin, J.
    Azad, A.
    Colyer, D.
    Shaw, M.
    Chander, S.
    Cuff, K.
    Wood, S.
    Lawrentschuk, N.
    Murphy, D.
    Pryor, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S248 - S248
  • [36] Should We be Offering Our Patients With Oligometastases Stereotactic Ablative Body Radiotherapy?
    Ostler, P.
    Hoskin, P.
    Martin, A.
    CLINICAL ONCOLOGY, 2021, 33 (12) : 747 - 748
  • [37] Stereotactic body radiotherapy of lymph node metastases under MR-guidance
    Herder-Wagner, C.
    Weykamp, F.
    Regnery, S.
    Hoegen, P.
    Renkamp, C. K.
    Liermann, J.
    Rippke, C.
    Koerber, S. A.
    Koenig, L.
    Buchele, C.
    Klueter, S.
    Debus, J.
    Hoerner-Rieber, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1230 - S1230
  • [38] Stereotactic radiotherapy for oligometastases in the lymph nodes
    Pasqualetti, Francesco
    Trippa, Fabio
    Aristei, Cynthia
    Borghesi, Simona
    Colosimo, Caterina
    Cantarella, Martina
    Mazzola, Rosario
    Ingrosso, Gianluca
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2022, 27 (01) : 46 - 51
  • [39] Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy - No
    Macbeth, F.
    Hughes-Davies, L.
    CLINICAL ONCOLOGY, 2021, 33 (12) : 749 - 750
  • [40] Stereotactic ablative body radiotherapy for the treatment of oligometastases: a single-institution experience
    Murphy, G. A.
    Elbeltagi, M.
    LUNG CANCER, 2018, 115 : S57 - S58
12345